PDF file - Department of Health and Ageing
PDF file - Department of Health and Ageing
PDF file - Department of Health and Ageing
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
National Notifiable Diseases Surveillance System, 2004<br />
Annual report<br />
Cholera<br />
Case defi nition – Cholera<br />
Only confirmed cases are reported.<br />
Confirmed case: Requires isolation <strong>of</strong><br />
toxigenic Vibrio cholerae O1 or O139.<br />
In 2004, there were fi ve cases <strong>of</strong> cholera notifi ed in<br />
Australia, two from Victoria, <strong>and</strong> one each from New<br />
South Wales, Queensl<strong>and</strong> <strong>and</strong> Western Australia.<br />
Four <strong>of</strong> these cases acquired their disease overseas:<br />
one in Indonesia, one in the Philippines, <strong>and</strong><br />
two in India. The place <strong>of</strong> acquisition <strong>of</strong> the fi fth case<br />
was unknown.<br />
All fi ve notifi cations were Vibrio cholerae serogroup<br />
O1. There were two El Tor biotype notifi cations <strong>and</strong><br />
two Ogawa serotypes reported. Table 11 summarises<br />
the serogroups, biotypes, serotypes <strong>and</strong> toxin<br />
producing status <strong>of</strong> these notifi cations.<br />
In 2004, there were several suspected cases <strong>of</strong><br />
SARS reported by jurisdictions. Enhanced surveillance<br />
by general practitioners <strong>and</strong> hospitals in<br />
Australia resulted in the testing <strong>of</strong> fi ve people with<br />
fever, respiratory symptoms <strong>and</strong> history <strong>of</strong> travel to<br />
China. All tests for SARS were negative.<br />
Cholera, plague, rabies, yellow fever, SARS, HPAIH<br />
<strong>and</strong> viral haemorrhagic fevers are <strong>of</strong> international<br />
public health importance <strong>and</strong> are notified to the World<br />
<strong>Health</strong> Organization. Although no local transmission<br />
had been reported in Australia, these diseases<br />
continue to occur around the world. Travellers are<br />
advised to seek information on the risk <strong>of</strong> contracting<br />
these diseases in their destinations <strong>and</strong> take appropriate<br />
measures. More information on quarantinable<br />
diseases <strong>and</strong> travel health can be found on the<br />
Australian Government <strong>Department</strong> <strong>of</strong> <strong>Health</strong> <strong>and</strong><br />
<strong>Ageing</strong> Website at: http://www.health.gov.au/internet/<br />
wcms/Publishing.nsf/Content/health-pubhlth-strategquaranti-index.htm<br />
Sexually transmissible infections<br />
In 2004, sexually transmissible infections (STIs)<br />
reported to NNDSS were chlamydial infection, donovanosis,<br />
gonococcal infections <strong>and</strong> for the first time<br />
two categories <strong>of</strong> syphilis: syphilis – infectious (primary,<br />
secondary <strong>and</strong> early latent) less than 2 years<br />
duration <strong>and</strong> syphilis – <strong>of</strong> greater than 2 years or<br />
unknown duration. The NNDSS also received reports<br />
on congenital syphilis. These conditions were notifiable<br />
in all states <strong>and</strong> territories.<br />
Other national surveillance systems that monitor<br />
STI in Australia include the Australian Gonococcal<br />
Surveillance Programme, which is a network <strong>of</strong> specialist<br />
laboratories, <strong>and</strong> the National Centre in HIV<br />
Epidemiology <strong>and</strong> Clinical Research.<br />
The national trends in the number <strong>and</strong> rates <strong>of</strong> STI<br />
notifi cations reported to the NNDSS between 2000<br />
<strong>and</strong> 2004 are shown in Table 4. In interpreting these<br />
data it is important to note that changes in notifi cations<br />
over time may not solely refl ect changes in<br />
disease prevalence. Increases in screening rates,<br />
more targeted screening, the use <strong>of</strong> more sensitive<br />
diagnostic tests, as well as periodic public awareness<br />
campaigns may contribute to changes in the<br />
number <strong>of</strong> notifi cations over time.<br />
Age adjusted notifi cation rates were calculated for<br />
Indigenous <strong>and</strong> non-Indigenous populations for jurisdictions<br />
that had Indigenous status data completed<br />
in more than 50 per cent <strong>of</strong> notifi cations. These data<br />
however, have to be interpreted cautiously as STI<br />
screening occurs predominantly in specifi c high-risk<br />
groups including Indigenous populations. Similarly,<br />
rates between males <strong>and</strong> females need to be interpreted<br />
cautiously as rates <strong>of</strong> testing for STI differ<br />
between the sexes.<br />
Table 11. Cholera notifications 2004, Australia, by notifying jurisdiction <strong>and</strong> case details<br />
Notifying<br />
jurisdiction<br />
Sex<br />
Age at<br />
onset<br />
Vibrio cholerae serogroup/biotype/<br />
serotype<br />
Toxin production<br />
Country <strong>of</strong><br />
acquisition<br />
NSW Male 45 Vibrio cholerae O1 El Tor Unknown Philippines<br />
Qld Female 50 Vibrio cholerae O1 Unknown Unknown<br />
Vic Female 23 Vibrio cholerae O1 Ogawa Not reported India<br />
Vic Female 34 Vibrio cholerae O1 El Tor Ogawa Not reported India<br />
WA Male 33 Vibrio cholerae O1 Unknown Indonesia<br />
CDI Vol 30 No 1 2006 35